Key facts
- MH3D’s last known valuation is $31.0M (Jan 2025).
- It has raised $3.3M; the latest was Early Stage VC ($3.3M) in Jan 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for MH3D
- ·The full record, as it builds
Funding rounds
No funding rounds for MH3D are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MH3D
Developer of nuclear imaging technology designed for medical research. The company's technology for pre-clinical studies in small animals like mice and rats offers resolution and the ability to image multiple isotopes simultaneously, enabling researchers to study a wider range of biological processes.
- Sector
- Healthcare
- HQ
- Ann Arbor, MI, United States
- Founded
- 2023
- Employees
- 5
- Website
- mh3dinc.com/
- Ownership
- Privately Held (backing)
MH3D doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MH3D shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MH3D in its N-PORT filings yet. We sweep new filings monthly.